摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Ethyl-2-(2-pyridin-3-ylethenyl)quinazolin-4-one

中文名称
——
中文别名
——
英文名称
3-Ethyl-2-(2-pyridin-3-ylethenyl)quinazolin-4-one
英文别名
——
3-Ethyl-2-(2-pyridin-3-ylethenyl)quinazolin-4-one化学式
CAS
——
化学式
C17H15N3O
mdl
MFCD01881464
分子量
277.32
InChiKey
YJAUZTRXBADWHL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    21
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    45.6
  • 氢给体数:
    0
  • 氢受体数:
    3

文献信息

  • Small Molecular Inhibitors of RAD51 Recombinase and Methods Thereof
    申请人:Mazin Alexander V.
    公开号:US20140080849A1
    公开(公告)日:2014-03-20
    The invention includes compositions comprising a selective small-molecule inhibitor of RAD51 recombinase and a pharmaceutically acceptable carrier. The invention further includes methods of treating or preventing cancer in a subject, comprising the step of administering to the subject the compositions contemplated within the invention.
  • SMALL MOLECULAR INHIBITORS OF RAD51 RECOMBINASE AND METHODS THEREOF
    申请人:Mazin Alexander V.
    公开号:US20160106751A1
    公开(公告)日:2016-04-21
    The invention includes compositions comprising a selective small-molecule inhibitor of RAD51 recombinase and a pharmaceutically acceptable carrier. The invention further includes methods of treating or preventing cancer in a subject, comprising the step of administering to the subject the compositions contemplated within the invention.
  • US9216177B2
    申请人:——
    公开号:US9216177B2
    公开(公告)日:2015-12-22
  • US9750742B2
    申请人:——
    公开号:US9750742B2
    公开(公告)日:2017-09-05
  • [EN] SMALL MOLECULE INHIBITORS OF RAD51 RECOMBINASE AND METHODS THEREOF<br/>[FR] INHIBITEURS À PETITES MOLÉCULES DE LA RECOMBINASE RAD51 ET PROCÉDÉS ASSOCIÉS
    申请人:PHILADELPHIA HEALTH & EDUCATIO
    公开号:WO2013105985A1
    公开(公告)日:2013-07-18
    The invention includes compositions comprising a selective small- molecule inhibitor of RAD51 recombinase and a pharmaceutically acceptable carrier, The invention further includes methods of treating or preventing cancer in a subject, comprising the step of administering to the subject the compositions contemplated within the invention.
查看更多